Chemicals And Materials Industry Reports

Reports > Chemicals And Materials > Selected Report

Global Newcastle Disease Vaccine Market Report 2018

Single User: $2999
Multiple User: $3999
Enterprise User: $5999


Report Summary:

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.


Scope of the Report:
This report focuses on the Newcastle Disease Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.

The worldwide market for Newcastle Disease Vaccine is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 340 million US$ in 2023, from 280 million US$ in 2017, according to a new GIR study.

Market Segment by Manufacturers, this report covers
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Live Vaccines
Killed Vaccines

Market Segment by Applications, can be divided into
Chicken
Duck & Goose
Other

There are 15 Chapters to deeply display the global Newcastle Disease Vaccine market.
Chapter 1, to describe Newcastle Disease Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Newcastle Disease Vaccine, with sales, revenue, and price of Newcastle Disease Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Newcastle Disease Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Newcastle Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Newcastle Disease Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Newcastle Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Market Analysis by Applications
1.3.1 Chicken
1.3.2 Duck & Goose
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merial
2.1.1 Business Overview
2.1.2 Newcastle Disease Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 CEVA
2.2.1 Business Overview
2.2.2 Newcastle Disease Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 QYH Biotech
2.3.1 Business Overview
2.3.2 Newcastle Disease Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ringpu Biology
2.4.1 Business Overview
2.4.2 Newcastle Disease Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Yebio
2.5.1 Business Overview
2.5.2 Newcastle Disease Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Harbin Veterinary Research Institute
2.6.1 Business Overview
2.6.2 Newcastle Disease Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck Animal Health
2.7.1 Business Overview
2.7.2 Newcastle Disease Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 DHN
2.8.1 Business Overview
2.8.2 Newcastle Disease Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Zoetis
2.9.1 Business Overview
2.9.2 Newcastle Disease Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 ChengDu Tecbond
2.10.1 Business Overview
2.10.2 Newcastle Disease Vaccine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Elanco (Lohmann)
2.11.1 Business Overview
2.11.2 Newcastle Disease Vaccine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 FATRO
2.12.1 Business Overview
2.12.2 Newcastle Disease Vaccine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 CAVAC
2.13.1 Business Overview
2.13.2 Newcastle Disease Vaccine Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Vaksindo
2.14.1 Business Overview
2.14.2 Newcastle Disease Vaccine Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Newcastle Disease Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Newcastle Disease Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Newcastle Disease Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Newcastle Disease Vaccine Market Analysis by Regions
4.1 Global Newcastle Disease Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Newcastle Disease Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Newcastle Disease Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
5 North America Newcastle Disease Vaccine by Countries
5.1 North America Newcastle Disease Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Newcastle Disease Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Newcastle Disease Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
6 Europe Newcastle Disease Vaccine by Countries
6.1 Europe Newcastle Disease Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Newcastle Disease Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Newcastle Disease Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
6.4 France Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Newcastle Disease Vaccine by Countries
7.1 Asia-Pacific Newcastle Disease Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Newcastle Disease Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Newcastle Disease Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
7.5 India Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
8 South America Newcastle Disease Vaccine by Countries
8.1 South America Newcastle Disease Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Newcastle Disease Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Newcastle Disease Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Newcastle Disease Vaccine by Countries
9.1 Middle East and Africa Newcastle Disease Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Newcastle Disease Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Newcastle Disease Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Newcastle Disease Vaccine Sales and Growth Rate (2013-2018)
10 Global Newcastle Disease Vaccine Market Segment by Type
10.1 Global Newcastle Disease Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Newcastle Disease Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Live Vaccines Sales Growth and Price
10.2.1 Global Live Vaccines Sales Growth (2013-2018)
10.2.2 Global Live Vaccines Price (2013-2018)
10.3 Killed Vaccines Sales Growth and Price
10.3.1 Global Killed Vaccines Sales Growth (2013-2018)
10.3.2 Global Killed Vaccines Price (2013-2018)
11 Global Newcastle Disease Vaccine Market Segment by Application
11.1 Global Newcastle Disease Vaccine Sales Market Share by Application (2013-2018)
11.2 Chicken Sales Growth (2013-2018)
11.3 Duck & Goose Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Newcastle Disease Vaccine Market Forecast (2018-2023)
12.1 Global Newcastle Disease Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Newcastle Disease Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Newcastle Disease Vaccine Market Forecast (2018-2023)
12.2.2 Europe Newcastle Disease Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Newcastle Disease Vaccine Market Forecast (2018-2023)
12.2.4 South America Newcastle Disease Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Newcastle Disease Vaccine Market Forecast (2018-2023)
12.3 Newcastle Disease Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Newcastle Disease Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Newcastle Disease Vaccine Market Share Forecast by Type (2018-2023)
12.4 Newcastle Disease Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Newcastle Disease Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Newcastle Disease Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 40249

Category: 13

Published date: 2018-06-20 19:55:05

Number of Pages: 129

Publisher Name: GIR

Over all Rating: 87 % (Average of Ratings provided by clients)